Table 2. Associations of MUFSG in the Third Trimester With CBCL Composite T Scores and Clinical Composite Index Variable Categorya.
CBCL composite scaleb | Composite T scores | Clinical index variable scores | ||
---|---|---|---|---|
B (95% CI) | P value | OR (95% CI)c | P value | |
Total Problems | 2.14 (0.29 to 3.98) | .02d | 1.83 (1.17 to 2.86) | .008d |
Internalizing Problems | 2.29 (0.47 to 4.11) | .01d | 1.48 (0.96 to 2.30) | .08 |
Externalizing Problems | 1.45 (−0.27 to 3.17) | .10 | 1.38 (0.83 to 2.28) | .21 |
Abbreviations: CBCL, Preschool Child Behavior Checklist; MUFSG, maternal urinary fluoride adjusted for specific gravity; OR, odds ratio.
Calculations are based on a total of 229 participants. B values and ORs are presented according to an IQR (ie, 0.68 mg/L [to convert to millimoles per liter, multiply by 0.05263]) increase in MUFSG. Analyses were adjusted for maternal age, prepregnancy body mass index, ethnicity by nativity, maternal education, household income, maternal cohabitation, and child sex.
For clinical composite index scores, normal = 0 and borderline clinical or clinical = 1. Higher CBCL scores indicate more symptoms of neurobehavioral problems.
ORs reflect the odds of having a score in the borderline clinical or clinical range compared with the normal range.
Denotes statistical significance.